Kaufman Rossin Wealth’s AbbVie ABBV Stock Holding History

Kaufman Rossin Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$263K	Sell	1,052 -30	-3%	-$6.45K	0.12%	83
2026 Q1	$235K	Sell	1,082 -278	-20%	-$61.7K	0.13%	89
2025 Q4	$311K	Sell	1,360 -7	-0.5%	-$1.59K	0.16%	100
2025 Q3	$317K	Buy	1,367 +281	+26%	+$57.2K	0.17%	91
2025 Q2	$202K	Sell	1,086 -114	-10%	-$21.2K	0.13%	133
2025 Q1	$251K	Buy	1,200 +23	+2%	+$4.47K	0.18%	109
2024 Q4	$209K	Buy	+1,177	New	+$216K	0.22%	35

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Kaufman Rossin Wealth's ABBV Position: Q2 2026 in Review

Kaufman Rossin Wealth reduced its AbbVie (ABBV) stake by 2.8% in Q2 2026, selling an estimated $6.45K and leaving 1,052 shares worth $263K. The position accounts for 0.12% of the portfolio, ranked #83.

Kaufman Rossin Wealth first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $317K in Q3 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Kaufman Rossin Wealth held 1,052 shares of AbbVie worth $263K as of Q2 2026.
Kaufman Rossin Wealth sold 30 AbbVie shares in Q2 2026, an estimated $6.45K.
AbbVie made up 0.12% of Kaufman Rossin Wealth's portfolio in Q2 2026, its #83 holding.
Kaufman Rossin Wealth first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
Kaufman Rossin Wealth's AbbVie position peaked at $317K in Q3 2025.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kaufman Rossin Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.